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and Vera Mahler1
Currently, most medical gloves are produced with a low content of natural rubber latex (NRL) protein. However,
they may be substituted by proteins of foreign origin to maintain specific properties of the material. The aim of
this study was to investigate the allergenicity and immunogenicity of unexpected proteins (i.e., soy and casein)
compared with NRL proteins in a murine model in BALB/c mice. All respective allergen sources (extracts from
three brands of NRL gloves, soy, and casein) were able to induce significant allergen-specific IgE and IgG1
responses. On average, the highest IgE induction occurred after immunization with NRL, followed by soy and
casein. Certain individuals from each treatment group exhibited levels of specific IgE as high as due to NRL. To
analyze further specific IgE responses on a single allergen level, we established a microarray based on
recombinant allergens for allergen-specific murine IgE detection. Besides specific IgE against rHev b 3, -6, -7, -8,
and -11, specific IgE against k-casein could be detected in mice immunized with NRL glove extract, indicating a
sensitization potential of the contained foreign protein. The substitution of genuine latex proteins by proteins
of foreign origin may lead to a shift and de novo increase in sensitization to the finished products.
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INTRODUCTION
Owing to an HIV-associated increase in the use of medical
gloves for single use, the prevalence of individuals allergic to
natural rubber latex (NRL) allergens has significantly in-
creased among health-care workers (HCWs) during the last
decade of the previous century (Turjanmaa, 1987; Arellano
et al., 1992). NRL allergens bound to powder particles
constituted occupational inhalative allergens that were easily
propagated by air and were accessible to airway sensitization
by inhalation.
By regulations (approved code of practice (TRGS) 540
(sensitizing substances)) powdered latex gloves were banned
from the work environment in December 1997 and the
amount of leachable protein had been limited to o30 mg/g
glove (recommendation by the Accident Prevention &
Insurance Association for Health Care Workers; BGW) in
Germany. Consequently, a decrease in annual incidence
rates of sensitization to NRL and a decrease in suspected and
proved cases of occupational contact urticaria caused by
NRL was observed (Allmers et al., 2004; Mahler, 2007).
Unlabeled foreign proteins (e.g., casein) could be found in
NRL gloves (Ylitalo et al., 1999) and may improve the
material properties of the finished product. However,
substitution of genuine latex proteins and exposure to
unexpected proteins of foreign origin may lead to a shift in
sensitization profiles and an increase in allergic reactions
elicited by the finished products.
To evaluate the allergenicity and immunogenicity of
unexpected proteins compared with NRL proteins, we
established a murine model in BALB/c mice.
RESULTS
Protein contents of NRL gloves
Total protein content of the analyzed glove brands (n¼ 16),
casein, and soy content are displayed in Table 1. The total
protein content varied widely (4–1,018mg/g glove) among the
different brands. Casein could be detected in the range
between 1 and 10 mg/g glove and was not in parallel to the
total protein content. In certain gloves (e.g., no. 14 and 15),
casein seems to be the relevant contributor to the total
protein. Soy protein was only detected in traces.
IgE responses and time course of IgE reactivity to
immunizations with NRL glove extracts, casein, and soy extract
To determine the murine-specific IgE to NRL, casein, and soy,
we first used a conventional in vitro detection system (ELISA)
to the natural proteins. All measurements of all serum
samples of each animal (n¼ 10 per group) were performed
in duplicate and are graphically presented as means
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(Figure 1). As reported previously (Mahler et al., 2000), latex-
specific IgE responses were detectable 4 weeks after the first
latex immunization (i.e., fifth bleeding, day 28 (Figure 1)).
The increase continued until the ninth bleeding (day 140) and
varied among the different brands (Figure 2). Statistical
significance (Po0.001) of latex-specific IgE antibody induc-
tion in comparison to the adjuvant control group was
detectable in mice immunized with extracts from glove no.
3 and 13 from day 56 (sixth bleeding, i.e., 4 weeks after the
third immunization), in mice immunized with glove no. 2 not
earlier than day 140. The latex-specific IgE response induced
by glove no. 13, containing a high protein content, was at
the same time statistically significant (Po0.001) over
the response induced by the two other glove extracts. In the
casein- and soy-treated groups, no latex-specific or cross-
reacting IgE antibodies could be determined. Latex-specific
IgG1 induction was statistically significant (Po0.001) from
day 14 (glove no. 3 (maximum at day 84) and day 56 (glove
no. 13 (maximum at day 140) and glove no. 2 (maximum at
day 112), respectively (data not shown).
Immunization with casein from bovine milk led to a
significant allergen-specific IgE induction (Po0.001) at day
84 as well as significant IgG1 induction from day 84 to the
end of study, with the highest antibody levels at the end of
the study (Figure S1). None of the other treatment groups
mounted casein-specific IgE or IgG antibodies.
In the active treatment group immunized with soy extract,
statistically significant soy-specific IgE induction (Po0.001)
was observed from day 28 to the end of study with a
maximum of the antibody level at the end of the study (Figure S2).
Soy-specific IgG1 antibodies were detectable from day 56 to
the end of study, with a maximum of antibodies at day 84.
None of the other treatment groups developed soy-specific
IgE or IgG antibodies, which demonstrates that there was no
cross-contamination (i.e., in the food of mice).
Determination of total serum IgE in the distinct treatment
groups
Induction of total serum IgE as determined by BD OptEIATM in
murine-pooled blood of each treatment group is in parallel to
specific immunizations (Figure 3). Owing to the lack of other
influence factors, it can be assumed that this increase of total
IgE is mainly caused by the rise of specific IgE antibodies
induced by the specific immunizations. The earliest and most
predominant rise in total IgE can be observed in the pooled sera
of mice immunized with gloves no. 3 and 13, whereas total IgE
levels in other treatment groups increase more slowly, but
constantly, to reach comparable levels at the end of study (day
196). At day 196, the total IgE level is highest in the treatment
group that had received extracts from glove no. 13. Identical IgE
levels are found in the pooled sera of mice treated with gloves
no. 2 and 3 as well as those treated with soy extract, followed
by the total IgE level of casein-treated mice.
Table 1. Total protein, casein, and soy content
(lg/g glove) of different glove brands (no. 1–16) as
determined by Lowry assay or ELISA, respectively
Glove no. Type
Total protein
(lg/g glove)
Casein content
(lg/g glove)
Soy content
(lg/g glove)
1 S 648 3.31 0.19
2 E 198 9.24 0.14
3 E 421 1.95 0.1
4 E 252 4.43 0.17
5 S 103 3.03 0.12
6 E 118 3.02 0.05
7 E 43 4.85 0.06
8 E 22 1.68 0
9 S 31.8 2.86 0.01
10 E 20 1.96 ND
11 E 737 3.48 0.23
12 E 120 4.58 0.06
13 E 1,018 5.62 0.3
14 S 4 4.34 ND
15 S 7 4.13 ND
16 E 22 1.4 ND
E, examination glove; ND, not done; S, surgical glove.
Immunization 1
1 2 3 4 5 6
0 7 14 21 28 35 42 49 56 63 70 77 84 112 140 158 196
2 3 4 5 6 7 8 9
7 8 9 10 11
(days)
Bleeding
Figure 1. Scheme of immunization. Six groups of mice (n¼ 10 per group)
were subcutaneously immunized in the neck with either aluminiumhydroxid-
adsorbed latex, casein, soy extracts, or adjuvant only.
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Figure 2. ELISA for latex-specific murine IgE. ELISA plates were coated
with extracts of glove no. 3. Mean values of each treatment group are
displayed. Level of significance (Po0.001) of latex-specific IgE induction
is displayed as **.
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Certain individuals of each group exhibited stronger IgE
levels than their peers from the same treatment group. These
high responders of all immunization groups showed compar-
able IgE levels (Figure 4).
Microarray analysis of allergen-specific murine IgE binding
To determine the individual component-resolved sensitiza-
tion profile (Heiss et al., 1999; Wagner and Breiteneder,
2005) in the respective treatment groups, a recombinant
allergen-based microarray for the detection of murine IgE
antibodies was established. Recombinant latex allergens and
native casein, as well as a-, b-, and k-casein were bound to
the solid phase of the chip. Representative animals of each
treatment group were examined for their component-resolved
sensitization (Table 2). Depending on the glove brand used
for immunization, specific murine IgE against rHev b 3, rHev
b 6, rHev b 7, rHev b 8, and rHev b 11 could be detected
(Table 2). Furthermore, a relevant amount of casein-specific
IgE could be detected in the serum of an individual
(IV-1) who had exclusively received NRL glove extract
(glove no. 13).
DISCUSSION
During the last decade of the previous century, the
predominant route of sensitization to NRL in HCW used to
be the inhalant route due to powder-bound latex compo-
nents, whereas Spina bifida patients were sensitized during
surgical interventions. However, due to regulatory interven-
tions in Germany (and other European countries) including
the ban of powdered gloves and production of disposable
gloves of low NRL protein content, production modalities,
composition of glove material (including unexpected proteins
to maintain material properties) as well as the exposure of
HCWs have changed.
It is not commonly known that cow’s milk casein can be
added as a stabilizer during glove manufacturing (Ylitalo
et al., 1999). In the analyzed set of 16 different gloves brands,
we found casein contents from 1 to 10 mg/g glove (Table 1)
and could confirm the earlier findings of casein additives in
the finished products (Ylitalo et al., 1999). In the previous
report from Finland (Ylitalo et al., 1999), the clinical
relevance of the addition of casein could be demonstrated
by positive in vivo IgE reactivity to the finished NRL glove
product in cow’s milk allergic and NRL skin prick test- and
radioallergosorbent test-negative patients.
Although according to European norm 1041 (DIN EN
1041, 1998) information has to be supplied by the
manufacturer, a complete labeling of all ingredients con-
tained in finished latex products is not given. However,
complete labeling constitutes a prerequisite for allergy
prevention.
The substitution of genuine latex proteins by proteins of
foreign origin may lead to a shift and an increase in
sensitization to extraneous allergenic components contained
in NRL gloves.
In our mouse model, we could demonstrate the in vivo
allergenicity of unexpected protein sources of foreign origin
(e.g., casein and soy) compared with NRL glove extracts. All
protein preparations of the different allergen sources were
capable of inducing highly significant levels (Po0.001) of
allergen-specific IgE. No crossreactivity of latex-induced IgE
(Figure 2), casein, or soy antibodies nor cross-contamination
(Figures S1 and S2) was observed. Although the dynamics of
the IgE induction as well as of the IgG1 induction varied from
allergen source to allergen source, in the end of the study,
comparable amounts of total IgE were observed in all
treatment groups (Figure 3) with the lowest IgE levels in the
casein-treated group. Casein (Bos d8) is composed of four
proteins (as1-, as2-, b-, and k-casein) (Elsayed et al., 2004).
Although the four proteins do not share many structural
similarities, most patients with cow’s milk allergy exhibit
specific IgE to all of them (Wal, 2001). Compared with
casein, the composition of latex and soy extracts is more
Pooled total-IgE (OptEIA)
10 BALB/c-mice per group
0.24
0.22
0.20
0.18
0.16
0.14
0.12
0.10
0 20 40
Days
An
tib
od
y-
tit
er
(O
D 
45
0 n
m)
60 80 100 120 140 160 180 200
glove 2 glove 3 glove 13
soy extract casein control group
Figure 3. Determination of total serum IgE in the distinct treatment groups.
Induction of total serum IgE in parallel to specific immunizations is
demonstrated in murine pooled blood of each treatment group.
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Figure 4. Total IgE of representative animals. Although the soy and casein
immunized groups showed lower amounts of total IgE antibodies in pooled
blood, certain mice achieve similarly high IgE levels as induced by NRL
extracts.
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complex, containing multiple IgE-binding components that
may contribute to the total allergenicity of the allergen
source. For soy, at least 28 soy IgE-binding proteins have
been described (Awazuhara et al., 1997; Cordle, 2004), and
for NRL, at least 13 identified allergens and more than 200
polypeptides (Posch et al., 1998; Wagner and Breiteneder,
2005) with a predominance of nHev b 6 in Hevea brasiliensis
serum have been described (Yeang et al., 2006).
In our microarray for component-resolved detection of
specific murine IgE, we were able to analyze the induced
in vivo allergen-specific immune responses individually on
the single-molecule level (Table 2). Individual animals
exhibit individual sensitization profiles to the glove-derived
allergenic components. Depending on the glove brand used
for immunization, specific IgE against rHev b 3, rHev b 6, rHev
b 7, rHev b 8, rHev b 11 as well as k-casein-specific IgE could
be detected in the murine sera (Table 2). Specific IgE raised
against rHev b 5, rHev b 9, and rHev b 10 were not detected.
Hev b 1 and b 3 are known as major allergens in latex-allergic
Spina bifida patients, whereas Hev b 5 and b 6 have been
recognized as major allergens in HCW. However, with a
prevalence of 7–32% in HCW and latex-allergic (not SB)
patients, Hev b 3 also constitutes a minor allergen in these
patients (Wagner and Breiteneder, 2005). Influences of the route
of exposure on sensitization profiles to allergens have been
described in BALB/c mice (Woolhiser et al., 2000). However, in
contrast to the results of this report based on immunization with
a single non-ammoniated latex extract and immunoblots of
pooled sera (n¼5), by microarray we could demonstrate an
individual and more complex IgE induction to several allergenic
components including rHev b 6 depending on the allergen
source administered by subcutaneous route.
The induction of comparable amounts of specific IgE to NRL,
casein, and soy (Figures 3 and 4) as well as the induction of
specific IgE to k-casein (individual IV-1 Table 2) after
immunization with a glove-derived extract (glove no. 13)
demonstrates the risk of de novo sensitization against foreign
protein sources added to NRL during the manufacturing process.
The amount of k-casein-specific IgE ranges between the levels of
specific IgE induced against certain genuine latex allergens such
as Hev b 3 and Hev b 8 (individual IV-1, Table 2).
This is in concordance with our finding that the amount of
total IgE induced in parallel with the specific immunizations in
certain individuals is higher than in their peers and in high
responders similar IgE levels can be observed after immuniza-
tion with the NRL extracts, casein, or soy, respectively (Figure 4).
On the basis of our findings, we conclude that unlabelled
substitution of NRL products with proteins from foreign allergen
sources constitutes a health threat with regard to de novo
sensitization as well as elicitation of pre-existing immediate-
type allergies against these independent allergen sources.
As a contribution to primary and secondary allergy
prevention, a substitution of allergenic NRL proteins by other
allergenic proteins from foreign allergen sources should be
avoided. However, if this substitution cannot be entirely
avoided due to material properties, complete information on
the composition of the glove material, including these
unexpected proteins, should be mandatory.
MATERIALS AND METHODS
Protein extraction of NRL gloves and protein quantification
Sixteen lots of different medical gloves were examined by extraction
of eight randomly sampled gloves from each lot according to
European norm 455-3 (DIN EN 455-3, 2000–02).
Table 2. Microarray analysis of allergen-specific murine IgE binding
Adjuvant
control
Glove
no. 2
Glove
no. 2
Glove
no. 2
Glove
no. 2
Glove
no. 3
Glove
no. 13
Glove
no. 13
Glove
no. 13 Casein Casein Buffer
Mice I–2 II–1 II–2 II–3 II–6 III–2 IV–1 IV–3 IV–4 IV–8 IV–9
a-Casein 0 0 0 0 0 0 0 0 0 0 1,546 0
b-Casein 0 0 0 0 0 0 0 0 0 0 1,433 0
k-Casein 0 0 0 0 0 0 3,168 0 0 5,670 14,163 0
Casein 0 0 0 0 0 0 0 0 0 738 4,829 0
rHev b 3 0 15,225 11,325 1,595 14,471 0 24,587 5,981 31,777 0 0 0
rHev b 5 0 0 0 0 0 0 0 0 0 0 0 0
rHev b 6 0 0 0 2,268 0 9,717 0 0 0 0 0 0
rHev b 7 0 0 2,331 0 0 0 0 0 0 0 0 0
rHev b 8 0 0 0 0 0 0 2,231 0 5,524 0 0 0
rHev b 9 0 0 0 0 0 0 0 0 0 0 0 0
rHev b 10 0 0 0 0 0 0 0 0 0 0 0 0
rHev b 11 0 0 0 1,780 0 1,263 0 0 0 0 0 0
FI, fluorescence intensity.
Component-resolved sensitization profiles of representative animals examined by microarray analysis are displayed. The respective immunization is
displayed above the identification of the individual animal. Depending on the glove brand used for immunization, rHev b 3, rHev b 6, rHev b 7, rHev b 8,
rHev b 11, and casein are recognized by the specific murine IgE antibodies. FI values X500 are displayed.
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The protein contents of the extracts were measured by the
modified Lowry assay (Lowry et al., 1951) following precipitation of
interfering substances. In brief, for precipitation, 100ml of 0.15% (w/v)
sodium desoxycholate was added to 1ml of each extract sample
incubated at room temperature (RT) for 30minutes. Subsequently,
100ml of 72% (w/v) trichloroacetic acid and 100 ml of 72% (w/v)
phosphotungstic acid were added and the samples incubated at RT
for 30minutes, thereafter centrifuged for 10minutes at 20,800
U/minute, the supernatant discarded, and the pellet dissolved in 200ml
of 0.1 M NaOH (yielding a fourfold concentration of each sample).
Protein was determined using the DC protein assay (Bio-Rad
Laboratories, Hercules, CA). Each sample was tested in duplicate
using four twofold serial dilutions. The optical density was read at
620 nm and the concentration of protein determined referring to the
ovalbumin protein standard.
Casein and soy quantification in NRL glove extracts and protein
preparation for immunization
Casein content in NRL glove extracts was determined using the
Casein Assay Kit (Tepnel, Biosystems, Flintshire, UK) according to
the manufacturer’s instructions. In brief, 100ml of diluted glove
extracts were incubated in microwells coated with anti-casein
antibody at RT. Plates were washed four times with 400ml Assay
Diluent between the respective incubation steps with 50 ml case-
in–biotin reagent, 50 ml avidin–horseradish peroxidase, and 50 ml
tetramethyl-benzidine substrate, and then read at 450 nm (Titertek;
Labsystems, Frankfurt a. M., Germany).
The intensity of the blue color reaction inversely correlates to the
amount of casein present in the glove sample. Comparison with a set
of casein standards allows the calculation of the casein level in the
original glove sample.
For quantification of soy content, ELISA plates were coated in
duplicate with 10 mg protein in 100 ml glove extract (10 mg per well)
and a serial dilution of a soy standard (1:16–1:512) overnight at 41C.
After two washes with phosphate-buffered saline (PBS)/0.05%
Tween 20 and a 2 hour-blocking step with PBS containing 1% BSA
(200ml per well) at RT, a rabbit anti-soy antibody (S 2519; Sigma-
Aldrich, Steinheim, Germany) at a dilution 1:2,000 in PBS/0.05%/
Tween 20/0.5% BSA was added overnight at 41C.
Thereafter, a peroxidase-labeled donkey anti-rabbit antibody (NA
934, Amersham, Freiburg, Germany) was added at a dilution 1:5,000
in PBS/0.05% /Tween 20/0.5% BSA overnight at 41C. Next day,
100ml 2,20-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) sub-
strate (Sigma, St Louis, MO) was added. The optical density
corresponding to the amounts of bound antibodies were determined
at 450 nm (Titertek; Labsystems).
For immunization, casein from bovine milk (purified powder,
Sigma-Aldrich) was suspended in aqua bidest, under shaking for
3 hours at 41C. Soy extracts were gained from isolated soybean protein
(ICN Biomedicals Inc. Aurora, OH) suspended in aqua bidest and
shaken for 3hours at 41C and centrifuged at 4,000 g (30minutes at
41C) to remove insoluble particles. For analysis of protein content,
protein extracts (125mg per cm gel) were separated by analytical
12.5% SDS polyacrylamide gel(Fling and Gregerson, 1986) and
visualized by Coomassie Blue staining (Bradford, 1976). A Rainbow
Marker (Amersham, Buckinghamshire, UK) was used as molecular
weight standard. Protein content was further analyzed by Lowry assay
(Lowry et al., 1951). Aliquots of 1ml were stored at 201C until use.
Immunization of mice
Sixty 8-week-old female BALB/c mice were purchased from Charles
River (Kislegg, Germany). The animals receiving a soy-free diet were
maintained in the animal care unit of the Department of
Dermatology of the University Hospital Erlangen according to the
local guidelines for animal welfare. As a sensitization protocol for
the mouse model a subcutaneous route was chosen, since due to ban
of powdered gloves (in Germany and other European countries) the
inhalant sensitization route especially in HCW no longer represents
the predominant sensitization route. Six groups consisting of 10 mice
each were subcutaneously immunized in the neck with adjuvant
adsorbed extracts obtained from three different glove brands (glove
no. 2, 3, and 13), soy, or casein on days 7, 14, and 28, consecutively
in 4-week intervals. For immunization representative glove brands
were chosen: no. 2 with an intermediate content of total protein and
a high content of casein; no. 3 with an intermediate content of total
protein and a low content of casein and no. 13 with a high content of
total protein and an intermediate content of casein.
Each injection contained 10 mg protein adsorbed to 200ml 2%
Al(OH)3 (AluGel-S; Serva, Heidelberg, Germany). As a negative
control, one group obtained the adjuvant Al(OH)3 containing 20 ml
of aqua bidest instead of protein extract. Blood samples were
obtained from the eye veins shortly before the first immunization
(preimmune serum) and subsequently before each consecutive
immunization (Figure 1).
Total serum IgE assay (BD OptEIATM)
For measurement of total murine IgE, the OptEIATM mouse IgE Kit
(BD Biosciences PharMingen, Heidelberg, Germany) was used
according to the manufacturer’s instructions.
Briefly, wells of 96-well Nunc-Maxisorb microtiter plates (Nunc,
Roskilde, Denmark) were coated with 100 ml of anti-mouse IgE mAb
at a 1:250 dilution in 0.1 M carbonate buffer (pH 9.5) overnight at
41C. Plates were washed with PBS/0.05% Tween 20 and blocked
with PBS with 10% fetal bovine serum (Assay Diluent, BD
PharMingen, Heidelberg, Germany). Serial dilutions of murine IgE
standard and serum samples in 10% fetal bovine serum in PBS were
added to the wells in duplicate. After 2 hours at RT, the plates were
washed and incubated with biotinylated anti-mouse IgE mAb and
avidin–horseradish peroxidase reagent for 1 hour at RT. The plates
were read at 450 nm (Titertek; Labsystems).
ELISA measurements
Mouse IgE and IgG1 antibodies from each individual and time of
bleeding were detected by ELISA as described previously (Mahler
et al., 2000). In brief, ELISA plates (Nunc-Maxisorb, Nunc) were
coated with 100 ml PBS containing 10 mg of the respective extracted
protein (NRL, soy, or casein) per well overnight at 41C. Plates were
washed twice with 200ml PBS/0.05% Tween 20 and incubated with
200ml blocking solution (PBS/0.05% Tween 20/1% BSA) for
2.5 hours at RT. Plates were then incubated with 100ml PBS-diluted
mouse sera per well overnight at 41C. For IgE measurements, sera
were diluted 1:20, for IgG1 measurements 1:1,000 in PBS/0.05%
Tween 20/0.5% BSA). After five washes with 200ml PBS/0.05%
Tween 20, bound mouse IgE and IgG1 antibodies were detected with
purified monoclonal anti-mouse IgE or IgG1 antibodies from rat
(PharMingen), which were diluted 1:1,000 in PBS/0.05% Tween 20/
0.5% BSA incubated overnight at 41C. Plates were washed five times
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with 200ml PBS/0.05% v/v Tween and bound rat antibodies were
detected with a peroxidase-coupled anti-rat Ig anti-serum from goat
(Amersham Pharmacia Biotech Europe, Freiburg, Germany) and
visualized with 2,20-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
substrate (Sigma, St. Louis, MO). The optical density corresponding
to the amounts of bound antibodies was determined at 450 nm
(Titertek; Labsystems). Possible plate-to-plate variabilities were
excluded by including reference sera on each of the different plates.
All measurements were performed in duplicate which did not differ
from each other more than 5%. Statistical analysis was performed as
described below. The time course of the measurements is presented
graphically.
Protein microarray for allergen-specific IgE detection
A customized, commercially available allergen microarray
(ISACTM version CRD 51, VBC Genomics Bioscience Research,
Vienna, Austria) was employed that has been shown to yield
reliable analytical results when compared with conventional
fluorescence enzyme immunoassays in other clinical and research
settings (Hiller et al., 2002; Jahn-Schmid et al., 2003; Wo¨hrl
et al., 2006).
The device consisted of a microscopy glass slide modified with a
TeflonTM mask to create four individual reaction sites coated with
amine-reactive polymers allowing covalent immobilization of 12
purified natural or recombinant allergen components (rHev b 3,
rHev b 5–11, native a-, b-, and k-casein) spotted onto the microarray
slide in vertical triplicates (Table 2).
Microarray immunoassays were performed according to the
manufacturer’s recommendations as recently published (Deinhofer
et al., 2004; Harwanegg and Hiller, 2005), using different secondary/
tertiary antibodies to detect murine IgE. Briefly, each microarray
reaction site was incubated with 20 ml of undiluted murine serum
for 180minutes to capture allergen-specific serum IgE antibodies
by their corresponding allergen molecules. In a second step,
the microarray slides were washed with Tris-buffered saline/Tween
(TBST) buffer solution twice for 5minutes, rinsed with deionized
water, and dried under nitrogen flow. Hereafter, microarray-bound
IgE was marked by co-incubation with a secondary, fluore-
scence-tagged rat anti-mouse IgE antibody (PharMingen) at a
concentration of 1 mgml1 for 60minutes at RT and a fluoro-
chrome-labeled goat anti-rat IgG antibody at a concentration of
4mgml1 (Alexa Fluor546; A11081; Invitrogen, Carlsbad, CA) as
tertiary antibody.
After a subsequent washing procedure with TBS-T, the corre-
sponding fluorescence signals were scanned at a 10 mm resolution
using a conventional biochip reader (Scan Array ExpressTM, Perkin
Elmer Life Sciences, Boston, MA) and dimensionless fluorescence
intensity values were measured.
Statistical analysis
Data entry was done using Microsoft (TM) Excel 97, the statistical
evaluation of the data was performed with Statistical Analysing
System (SAS Inst. Inc., Cary, NC) version 8.2. Win. The distribution
of the ELISA-measured values by group and time was described using
mean and standard deviation, possible differences between the
groups were calculated using repeated measurement analysis of
variance technique. Level of significance, a, was set to 5%. The
course over time was visualized graphically.
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